Home > Insider Trading > Filing (0001104659-21-144593)

Filing Details

Accession Number:: 0001104659-21-144593
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-29 20:01:04
Reporting Period:: 2021-06-17

Accepted Time:: 2021-11-29 20:01:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1558569	Ispecimen Inc.	ISPC	Services-Commercial Physical & Biological Research (8731)	270480143

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1857013	L. Andrew Ross	C/O Ispecimen Inc. 450 Bedford Street Lexington MA 02420		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-17	100	$6.27	1,310,624	No	4	P	Direct
Common Stock	Acquisiton	2021-06-23	400	$6.52	1,311,024	No	4	P	Direct
Common Stock	Acquisiton	2021-11-08	1,000	$5.73	1,312,024	No	4	P	Indirect	By Wingood Capital LLC
Common Stock	Acquisiton	2021-11-10	500	$5.85	1,312,524	No	4	P	Direct
Common Stock	Acquisiton	2021-11-15	500	$5.29	1,313,024	No	4	P	Direct
Common Stock	Acquisiton	2021-11-15	500	$5.30	1,313,524	No	4	P	Direct
Common Stock	Acquisiton	2021-11-16	1,000	$5.19	1,314,524	No	4	P	Indirect	By Wingood Capital LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	By Wingood Capital LLC
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	By Wingood Capital LLC

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options	Acquisiton	2021-07-30	13,525	$0.00	13,525	$0.00
Common Stock	Restricted Stock Units	Acquisiton	2021-07-30	2,500	$0.00	2,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,525			No	4	A	Direct
2,500			No	4	A	Direct

Footnotes

Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement.
The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company.
Including 1,310,524 shares of common stock acquired by the Reporting Person on June 21, 2021, as reported in the Form 4 filed with the Securities and Exchange Commission on June 23, 2021.